Drug interaction trial of BMS 986094 and simeprevir.

Trial Profile

Drug interaction trial of BMS 986094 and simeprevir.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 23 Aug 2012

At a glance

  • Drugs BMS 986094 (Primary) ; Simeprevir
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Aug 2012 Status changed from planning to discontinued prior to enrolment.
    • 23 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top